Conns【CONN】銘柄情報 | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Conns Inc (CONN) 銘柄情報

Conns Inc (CONN)

0.0975

0.00

(0.00%)

終了 12月27日 6:00AM

0.00

0.00

(0.00%)

取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0975

買値

0.0835

売値

0.0836

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

0.0975

始値

-

時刻

最終取引時間

平均取引量 (3 か月)

-

財務取引量

-

VWAP

-

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Conn’s, Inc. Announces Receipt of Delinquency Notification Letter from Nasdaq

THE WOODLANDS, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Conn’s, Inc. (NASDAQ: CONN) (“Conn’s” or the “Company”), a specialty retailer of home goods, including furniture and mattresses...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form 8-K - Current report

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CONN - Frequently Asked Questions (FAQ)

What is the current Conns share price?

The current share price of Conns is US$ 0.0975

What is the 1 year trading range for Conns share price?

Conns has traded in the range of US$ 0.00 to US$ 0.00 during the past year

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AIREreAlpha Tech Corporation	US$ 3.5701 (160.59%)	130.88M
SPRCSciSparc Ltd	US$ 0.50 (126.04%)	239.51M
ZCARZoomcar Holdings Inc	US$ 2.80 (95.80%)	60.3M
MGIHMillennium Group International Holdings Ltd	US$ 2.9698 (94.10%)	75.35M
SKKSKK Holdings Limited	US$ 1.35 (80.48%)	52.11M
LNKSLinkers Industries Ltd	US$ 3.295 (-65.64%)	3.65M
GTIGraphjet Technology	US$ 0.3354 (-45.02%)	22.44M
BAOSBaosheng Media Group Holdings Ltd	US$ 4.3979 (-38.06%)	1.97M
NEUPNeuphoria Therapeutics Inc	US$ 4.34 (-34.54%)	599.97k
SVRESaverOne 2014 Ltd	US$ 1.0501 (-30.46%)	1.36M
XTIAXTI Aerospace Inc	US$ 0.0398 (1.53%)	270.76M
SPRCSciSparc Ltd	US$ 0.50 (126.04%)	239.51M
COEPCoeptis Therapeutics Holdings Inc	US$ 0.213249 (50.18%)	205.2M
RGTIRigetti Computing Inc	US$ 15.445 (36.08%)	204.3M
SMXSMX Security Matters Public Company	US$ 0.3303 (51.51%)	172.17M

rakp

Charles Schwab won't allow trading anymore in this company.

Thanks to Chris and company for all the wonderful stories in the past......

NickyCapone

NickyCapone 4分前

This was just a brisk walk to .83 today‼️

$Tay tune for the Moon run once volume is here‼️

rickstereo3333

rickstereo3333 5分前

Apparently the Muppet doesn't understand what Vivos meant when they clearly stated,..."This milestone trial, which has commenced with the successful treatment of five patients with cancerous lymph nodes, represents a transformative step in advancing innovative cancer therapies.".

Hi

JJ8

Interesting check in chart that makes me laugh.

One could choose either interpretation:

1. Long Tail Up since 23-Dec-2024. This is negative and suggest price is likely to correct.

2.. Histogram bars pointing to likely recovery in share price.

BDEZ

Hobbs & Fontes rigged 2 consecutive elections against Kari Lake

https://x.com/Real_RobN/status/1871965421470912693

6of1

you think AI is hot have a look at quantum

norisknorewards

norisknorewards 8分前

or they get (impo) approval the price explodes and shorts are destroyed.

End of the day...You, nor I, know what is coming. I am far more calm than you are.

That's what I am confident of

BDEZ

58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.

BDEZ

58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.

willyw

willyw 11分前

Yes, I'm enjoying the discussions. Yes, EDP 235 may never get a phase 3 trial- OTOH, if covid vaccinations continue to decline and IF another Delta like covid variant were to become prevalent we might wish we had a better drug than Paxlovid. And in spite of Paxlovid's possible inferiority to other c

Genz2

https://www.prnewswire.com/news-releases/nagravision-and-airties-partner-to-enhance-consumer-cybersecurity-for-homes-and-small-businesses-302265593.html

Excerpt:

NAGRAVISION solutions are designed to empower consumers and businesses to thrive in a connected world withou

Stockman1010101

Stockman1010101 15分前

he is no genius but a scam artists. He makes over $25 million per year salary when he causes the AMC stock to tank. He has not bought 1 AMC shares since he took over the CEO position in 2016. The man is WORST CEO OF ANY STRUGGLING CO IN WALLSTREET
HE LIED AND DISTORTED THE TRUTH TO THE SHARE

SkyLimit2022

SkyLimit2022 16分前

Gro,

Are you sure that your statement reflects reality? I think you’re just posting random nonsense as usual. 😶

“Big Pharma companies focus on compelling science, intellectual property, and promising clinical trial data, not necessarily the company’s market l

lakers17

lakers17 17分前

For sure. Those new OTC filing rules in 2021 killed the OTC overall and the created expert market was a death sentence for many OTCs. The one guy screaming that 2021 is back over and over is absurd as are his charts in OTCs, especially trip plays. They don't work in the OTC and no way a chart pre

RealDutch

RealDutch 20分前

We could easily lose the partners in Nigeria if Laxmi keeps sending these crappy emails. They are also on his email list. They will not understand WHAT THE HELL IS GOING ON HERE.

We have to end this HERE, and NOW. How can anyone disagree with this?

123tom

123tom 22分前

👍️ look for patterns.
Measurement patterns.Fib retrace targets. Shoulder support levels. 1 dollar 2 dollar moves. Now 3 dollar. Need more time to see some patterns. I might defer to any insights from Citrati and his charts.
Steve/ sab... 🫡 your forecast was proved rig

glens0

glens0 22分前

Read this post, "ASST 8-k just out. Got extension til June 16,2025 to regain compliance. Be interesting to see if they release news.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1920406/000121390024112672/ea0226060-8k_asset.htm
https://investorshub.advfn.com/boards/read_msg.aspx?mes

Not likely

Not likely 22分前

Oh ffs...

What's with you meatheads???

This site is littered with you like.

Grade schoolers comprehend more then you lot.

The ignorance is astounding.

Smfh.

JJ8

Good to know that you are in charge. Thanks for the great response.

Let's do it right with with what looks like a great opportunity with SoundHound stock to make some mula.

Thanks for your wishes and in turn I wish you and other investors in SOUN the same.

Hardazoak

Hardazoak 25分前

dstock07734

dstock07734 26分前

Repeat after me: One of the most amazing part about DCVax-L is that success in animal models translates to humans. We are talking about the translation of success not about good or bad animal models.

I really don't think you read hundreds of papers. Each of following trial had preclin

Hardazoak

Hardazoak 26分前

All you bashers need to go slow on that fetanyl/meth mix. Making you talk nonsense all day long, going in circles about yellow corn tortilla taco factory, Benny- russian mafia conspiracy.

Societe Generale Effekten

L&G India INR Gov Bond U...

iShares Global Infrastru...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約